3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
211
Thoracic
39
Gastrointestinal
39
Gynecologic
29
Breast
21
Head & Neck
19
Dermatologic
18
Sarcoma
9
CNS
6
Other solid neoplasm
5
Plasma cell
4
Other hematologic neoplasm
4
Lymphoid
4
Myeloid
3
Endocrine
3
NET
1
Conditions
Neuroendocrine Tumors
69
Gastro-enteropancreatic neuroendocrine tumor
8
Pheochromocytoma
7
Carcinoma, Neuroendocrine
7
Carcinoid Tumor
7
Adenoma, Islet Cell
7
Paraganglioma
6
Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Thyroid Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Carcinoma
4
Serotonin Syndrome
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Mesothelioma
3
Meningioma
3
Liver Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Merkel Cell
3
Carcinoma, Hepatocellular
3
Anus Neoplasms
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
NET
×
90 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled